While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
P eter Hotez has made every effort to stay up to date with Covid-19 vaccines, starting with the initial two doses and ...
Big news in health: The Food and Drug Administration has approved new COVID-19 vaccines from Pfizer and Moderna. The ...
The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.
Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory ...
All new Pfizer and Moderna vaccines target the Omicron variant KP ... In the future, we may even need two or more booster doses per year, says Dr. Priya Sampathkumar, an infectious disease ...
The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...